Andreas Halvorsen – ADPT history
- Issuer:
- ADAPTIVE BIOTECHNOLOGIES COR
- Quarters tracked:
- 24 (Q1 2021 → Q1 2026)
- Current shares:
- 29,993,708
- Current value:
- $416.31M
- Peak shares:
- 29,993,708 (Q1 2021)
- Overall change:
- 0%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 29,993,708 | $416.31M | $13.88 | 0 | 0% |
| Q4 2025 | 29,993,708 | $487.10M | $16.24 | 0 | 0% |
| Q3 2025 | 29,993,708 | $448.71M | $14.96 | 0 | 0% |
| Q2 2025 | 29,993,708 | $349.43B | $11650.00 | 0 | 0% |
| Q2 2025 | 29,993,708 | $349.43M | $11.65 | 0 | 0% |
| Q1 2025 | 29,993,708 | $222.85M | $7.43 | 0 | 0% |
| Q1 2025 | 29,993,708 | $222.85B | $7430.00 | 0 | 0% |
| Q4 2024 | 29,993,708 | $179.81M | $5.99 | 0 | 0% |
| Q4 2024 | 29,993,708 | $179.81B | $5995.00 | 0 | 0% |
| Q3 2024 | 29,993,708 | $153.57M | $5.12 | 0 | 0% |
| Q2 2024 | 29,993,708 | $108.58M | $3.62 | 0 | 0% |
| Q1 2024 | 29,993,708 | $96.28M | $3.21 | 0 | 0% |
| Q4 2023 | 29,993,708 | $146.97B | $4900.00 | 0 | 0% |
| Q3 2023 | 29,993,708 | $163.47B | $5450.00 | 0 | 0% |
| Q2 2023 | 29,993,708 | $201.26B | $6710.00 | 0 | 0% |
| Q1 2023 | 29,993,708 | $264.84B | $8830.00 | 0 | 0% |
| Q4 2022 | 29,993,708 | $229.15M | $7.64 | 0 | 0% |
| Q3 2022 | 29,993,708 | $213.56M | $7.12 | 0 | 0% |
| Q2 2022 | 29,993,708 | $242.65M | $8.09 | 0 | 0% |
| Q1 2022 | 29,993,708 | $416.31M | $13.88 | 0 | 0% |
| Q4 2021 | 29,993,708 | $841.62M | $28.06 | 0 | 0% |
| Q3 2021 | 29,993,708 | $1.02B | $33.99 | 0 | 0% |
| Q2 2021 | 29,993,708 | $1.23B | $40.86 | 0 | 0% |
| Q1 2021 | 29,993,708 | $1.21B | $40.26 | — | NEW |